Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk


5/29/2015 Update on Russian Import of Pharmaceutical Drugs (April 2015)

In April 2015, the Russian import of ready-made pharmaceutical drugs started to decrease, which is characteristic of that time of the year, but this year, it began a month earlier than usual. The volume of import fell by 14%, compared to March. In absolute terms, Russia imported 30.6 mln RUR worth of pharmaceutical drugs in April. In physical terms, the volume of import has decreased by 16% over the past year, which is also a sign of a downward trend...

5/22/2015 Rating of Banks Performing Payment Transactions of Russian Import of Pharmaceutical Drugs (Q1 2015)

Nearly 70 banks perform payment transactions of the import of pharmaceutical drugs to Russia, with the top-5 banks performing 69.4% of all the transactions made in the first quarter of 2015...

5/20/2015 Rating of Russian Retail Pharmacies (Q1 2015)

The beginning of the year for retail pharmacies was not only highlighted by further development of the economic crisis, demand fluctuation and a number of regulatory initiatives...

5/5/2015 RNC Pharma Updates Info on Russian Import of Pharmaceutical Drugs (March 2015)

In March 2015, the volume of the Russian import of ready-made pharmaceutical drugs remained almost the same and amounted to 35.4 bln RUR. Over the year, the import expenditures has risen by 12%. However, the actual volume of import is decreasing, compared to March 2014, as it has fallen by 1.1% over the year...

4/29/2015 RNC Pharma Celebrates 2nd Anniversary

On April 29, 2013, a new analytical company was registered with the unified state register of legal entity. This company was RNC Pharma. Everything went well, and the company was registered in the Interdistrict Inspection of the Russian Federal Tax Service #46...

4/7/2015 RNC Pharma Updates Info on Russian Import of Pharmaceutical Drugs (February 2015)

In February 2015, Russia imported 35.2 bln RUR worth of ready-made pharmaceutical drugs, with the import expenditures rising by 22%, compared to 2014. The actual volume of import has fallen by 8.5% over the year, continuing the trend that started in January. As for the preferred currency, we can see the previous year’s trends returning – the percentage of contracts concluded in rubles has risen from 90% in January to 94% in February...

3/31/2015 Import Substitution in Russia

In the current economic and political environment, import substitution is one of the key drivers of the Russian pharmaceutical market. Soon, we can expect more than 70 Russian alternatives to 30 INNs out of the 57 strategically important pharmaceutical drugs alone. RNC Pharma presents the results of the research of import substitution and localization in the Russian pharmaceutical market...

3/27/2015 Pharmaceutical Crisis

On March 26, Moscow hosted a Russian Association of Pharmaceutical Marketing (RAPM) conference, “New Threats and Opportunities of Russian Pharmaceutical Market in 2015”. Within the agenda of the conference, RNC Pharma published a forecast of the Russian pharmaceutical market after the monetary crisis of 2014-2015...

3/4/2015 Freight Heights